- Home
- WLTH vs MLTX Comparison
WLTH vs MLTX Comparison
Compare WLTH & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$17.67
Company Overview
Basic Information| Metric | WLTH | MLTX |
|---|---|---|
| Founded | 2008 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | WLTH | MLTX |
|---|---|---|
| Price | $8.55 | $17.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $17.13 | ★ $24.80 |
| AVG Volume (30 Days) | 1.2M | ★ 1.2M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.25 | N/A |
| Revenue Next Year | $14.99 | N/A |
| P/E Ratio | $10.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.20 | $5.95 |
| 52 Week High | $14.12 | $62.75 |
Technical Indicators
Market Signals| Indicator | WLTH | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.17 | 57.13 |
| Support Level | $7.63 | $14.84 |
| Resistance Level | $9.25 | $19.15 |
| Average True Range (ATR) | 0.66 | 0.99 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 57.02 | 54.74 |
Price Performance
Historical Comparison WLTH
MLTX
About WLTH Wealthfront Corporation Common Stock
Wealthfront Corp is a technology company that built a financial solutions platform for digital natives. Its platform is designed to address the needs of the wealth builders within these generations.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.